Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

DNA methylation may influence the effects of aspirin in patients with breast cancer

Women with a particular DNA feature may live longer if they take aspirin even before they are diagnosed with breast cancer, a new study found.

13 Aug 2019

Age-related hearing loss could be prevented with development of novel drug

The first ever medication to treat age-related hearing loss could potentially receive FDA approval through a comprehensive study being conducted at the University of South Florida.

12 Aug 2019

Survey shows increasing use of opioids to treat migraine headaches

An increasing number of Americans are using opioids to treat their migraine headaches, despite the fact that opioids are not the recommended first-line therapy for migraine in most cases.

7 Aug 2019

New drug could be used for future treatments of brain tumors

A new drug, known as IP1867B, could be used for future treatments of brain tumors.

6 Aug 2019

Children with medical emergencies get only limited help during airline flights

Children afflicted with medical emergencies during commercial airline trips tend to have common ailments such as vomiting, fever or allergic reactions - events that should be easily treated, according to a study led by Duke Health researchers.

25 Jul 2019

Researchers harness the pain-relieving properties of cannabis to develop new pain killers

The cannabis plant produces pain-relieving molecules that are 30x more effective than aspirin. Researchers are now working on a plant-based pain killer.

25 Jul 2019

It is okay for women with lupus to get pregnant with proper care, says new study

Systemic lupus erythematosus (SLE) is an autoimmune disease which was historically perceived to confer an unacceptably high risk to both mother and child during pregnancy. As a result, most women with the condition were counseled to avoid pregnancy or to terminate their pregnancy.

10 Jul 2019

Research sheds light on ‘black box’ of inpatient opioid use

People who receive opioids for the first time while hospitalized have double the risk of continuing to receive opioids for months after discharge compared with their hospitalized peers who are not given opioids, according to research led by scientists at the University of Pittsburgh Graduate School of Public Health.

18 Jun 2019

Polygenic risk scores based on entire genome sequence may reliably predict heart disease

Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.

11 Jun 2019

New research provides welcomed news for countless patients taking PPIs

For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.

7 Jun 2019

‘Promising’ results for beating heart patch that repairs heart cells after cardiac arrest

Researchers have developed a blood test that flags up heart failure early on and a “pumping” patch that could help to repair heart damage after an attack.

4 Jun 2019

Scientists identify target to ‘tone down’ hyper-active immunity to influenza infection

For most people, the influenza A virus, commonly known as the flu, is cleared from the body by our own immune system.

23 May 2019

People with stroke can take common medicines without raising risk of another stroke

People who suffer a stroke caused by bleeding in the brain - known as brain hemorrhage - can take common medicines without raising their risk of another stroke, a major clinical trial has found.

23 May 2019

University of Virginia chemist identifies potential addiction-free pain reliever

An estimated 1.7 million Americans suffer from substance abuse disorders related to opioid use for pain relief, according to the National Institute on Drug Abuse.

17 May 2019

Scientists solve mystery surrounding mechanical forces that influence blood clotting

Researchers at the University of Sydney have used biomechanical engineering techniques to unlock the mystery surrounding the mechanical forces that influence blood clotting.

5 Apr 2019

Drug that looks at Alzheimer’s differently ready for its first in-human testing

Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives.

4 Apr 2019

Aspirin could be used to treat patients with severe tuberculosis infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

26 Mar 2019

Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events

Taking a high dose of icosapent ethyl--a pure and stable prescription form of the omega-3 fatty acid known as EPA--significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

Study indicates the benefits of stopping aspirin in heart attack patients

Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.